Drug Shortage Report for BUPROPION SR
Report ID | 106721 |
Drug Identification Number | 02391562 |
Brand name | BUPROPION SR |
Common or Proper name | BUPROPION |
Company Name | SANIS HEALTH INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BUPROPION HYDROCHLORIDE |
Strength(s) | 100MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | 60 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-02-19 |
Estimated end date | 2020-03-23 |
Actual end date | 2020-03-23 |
Shortage status | Resolved |
Updated date | 2020-03-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-03-24 | English | Compare |
v7 | 2020-03-23 | French | Compare |
v6 | 2020-03-23 | English | Compare |
v5 | 2020-03-10 | French | Compare |
v4 | 2020-03-10 | English | Compare |
v3 | 2020-02-20 | English | Compare |
v2 | 2020-02-19 | French | Compare |
v1 | 2020-02-19 | English | Compare |
Showing 1 to 8 of 8